BioCentury
ARTICLE | Finance

Less to gain

Why biotech stocks missed out on the tax reform rally in 4Q17

December 22, 2017 10:34 PM UTC

While most of the stock market partied in 4Q17 as the tax reform bill approached the goal line, biotech stocks have sulked in the corner.

Republicans turned their full attention to tax reform in late September and after a flurry of amendments and horse trading, the Tax Cuts and Jobs Act (H.R. 1) was signed into law by President Donald Trump on Friday...